Evidence map›Paper›PMID 39106477›Full record

SynthesisJMIR aging2024

Markerless Motion Capture to Quantify Functional Performance in Neurodegeneration: Systematic Review.

Julian Jeyasingh-Jacob, Mark Crook-Rumsey, Harshvi Shah, Theresita Joseph, Subati Abulikemu, Sarah Daniels, David J Sharp, Shlomi Haar

Abstract readSystematic Review
In one paragraph

Synthesis in JMIR aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Walking as a Window to the Brain: Redefining Gait in Neurology.Medical sciences (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sensors in Multiple Sclerosis.Current neurology and neuroscience reports · 2025
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julian Jeyasingh-JacobDepartment of Brain Sciences, Imperial College London, London, United Kingdom.ORCID 0000-0001-7135-8470
Mark Crook-RumseyCare Research and Technology Centre, UK Dementia Research Institute, Imperial College London, London, United Kingdom.ORCID 0000-0003-3031-3502
Harshvi ShahDepartment of Brain Sciences, Imperial College London, London, United Kingdom.ORCID 0009-0001-1793-3160
Theresita JosephDepartment of Brain Sciences, Imperial College London, London, United Kingdom.ORCID 0009-0005-9110-0182
Subati AbulikemuDepartment of Brain Sciences, Imperial College London, London, United Kingdom.ORCID 0009-0008-4970-2173
Sarah DanielsDepartment of Brain Sciences, Imperial College London, London, United Kingdom.ORCID 0000-0002-7415-1907
David J SharpDepartment of Brain Sciences, Imperial College London, London, United Kingdom.ORCID 0000-0003-4995-2240
Shlomi HaarDepartment of Brain Sciences, Imperial College London, London, United Kingdom.ORCID 0000-0003-2213-6585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMarkerless motion capture (MMC) uses video cameras or depth sensors for full body tracking and presents a promising approach for objectively and unobtrusively monitoring functional performance within community settings, to aid clinical decision-making in neurodegenerative diseases such as dementia.

objectiveThe primary objective of this systematic review was to investigate the application of MMC using full-body tracking, to quantify functional performance in people with dementia, mild cognitive impairment, and Parkinson disease.

methodsA systematic search of the Embase, MEDLINE, CINAHL, and Scopus databases was conducted between November 2022 and February 2023, which yielded a total of 1595 results. The inclusion criteria were MMC and full-body tracking. A total of 157 studies were included for full-text screening, out of which 26 eligible studies that met the selection criteria were included in the review. .

resultsPrimarily, the selected studies focused on gait analysis (n=24), while other functional tasks, such as sit to stand (n=5) and stepping in place (n=1), were also explored. However, activities of daily living were not evaluated in any of the included studies. MMC models varied across the studies, encompassing depth cameras (n=18) versus standard video cameras (n=5) or mobile phone cameras (n=2) with postprocessing using deep learning models. However, only 6 studies conducted rigorous comparisons with established gold-standard motion capture models.

conclusionsDespite its potential as an effective tool for analyzing movement and posture in individuals with dementia, mild cognitive impairment, and Parkinson disease, further research is required to establish the clinical usefulness of MMC in quantifying mobility and functional performance in the real world.

Indexed as

Cognitive DysfunctionMotion CaptureActivities of Daily LivingDementiaHumansNeurodegenerative DiseasesParkinson DiseasePhysical Functional Performancebody trackingclinical decision makingdecisiondecision makingdementiamarkerless motion capturemild cognitive impairmentmobilitymonitoringmotionmotion analysismovementmovement analysisneurodegenerationneurodegenerativeneurodegenerative diseaseParkinson's diseasesystematic reviewtooltracking

Identifiers

PMID39106477
PMCPMC11336506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.